NEONC TECHNOLOGIES HOLDINGS, INC. Operating Expenses
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) reported Operating Expenses of $14.07 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-10
- NEONC TECHNOLOGIES HOLDINGS, INC. operating expenses for the quarter ending 2026-06-30 was $14.07M, a 146.49% increase year-over-year.
- NEONC TECHNOLOGIES HOLDINGS, INC. operating expenses for the quarter ending 2026-03-31 was $7.06M, a 77.91% decline year-over-year.
- NEONC TECHNOLOGIES HOLDINGS, INC. operating expenses for the quarter ending 2025-12-31 was $13.70M, a 541.92% increase year-over-year.
- NEONC TECHNOLOGIES HOLDINGS, INC. operating expenses for the quarter ending 2025-09-30 was $6.93M, a 215.61% increase year-over-year.
- NEONC TECHNOLOGIES HOLDINGS, INC. operating expenses for fiscal 2025 was $58.28M, a 706.59% increase from fiscal 2024.
- NEONC TECHNOLOGIES HOLDINGS, INC. operating expenses for fiscal 2024 was $7.23M.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14.07M 10-Q · filed 2026-08-10 | $21.13M 10-Q · filed 2026-08-10 | $34.82M derived: sum of 3 quarters · filed 2026-08-10 | $41.76M derived: sum of 4 quarters · filed 2026-08-10 | ||
| 2026-03-31 | $7.06M 10-Q · filed 2026-05-15 | $20.75M derived: sum of 2 quarters · filed 2026-05-15 | $27.69M derived: sum of 3 quarters · filed 2026-05-15 | $33.40M derived: sum of 4 quarters · filed 2026-08-10 | ||
| 2025-12-31 | $13.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $20.63M derived: sum of 2 quarters · filed 2026-03-31 | $26.34M derived: sum of 3 quarters · filed 2026-08-10 | $58.28M 10-K · filed 2026-03-31 | ||
| 2025-09-30 | $6.93M 10-Q · filed 2025-11-14 | $12.64M derived: sum of 2 quarters · filed 2026-08-10 | $44.58M 10-Q · filed 2025-11-14 | $46.72M derived: sum of 4 quarters · filed 2026-08-10 | ||
| 2025-06-30 | $5.71M 10-Q · filed 2026-08-10 | $37.61M 10-Q · filed 2026-08-10 | $37.65M 10-Q · filed 2025-08-18 | $39.78M derived: sum of 3 quarters · filed 2026-08-10 | $41.98M derived: sum of 4 quarters · filed 2026-08-10 | |
| 2025-03-31 | $31.94M 10-Q · filed 2026-05-15 | $37.62M 10-Q · filed 2025-05-09 | $34.07M derived: sum of 2 quarters · filed 2026-05-15 | $36.27M derived: sum of 3 quarters · filed 2026-05-15 | $37.57M derived: sum of 4 quarters · filed 2026-05-15 | |
| 2024-12-31 | $2.13M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $4.33M derived: sum of 2 quarters · filed 2026-03-31 | $5.63M derived: sum of 3 quarters · filed 2026-03-31 | $7.23M 10-K · filed 2026-03-31 | ||
| 2024-09-30 | $2.20M 10-Q · filed 2025-11-14 | $3.50M derived: sum of 2 quarters · filed 2025-11-14 | $5.09M 10-Q · filed 2025-11-14 | |||
| 2024-06-30 | $1.30M 10-Q · filed 2025-08-18 | $2.89M 10-Q · filed 2025-08-18 | ||||
| 2024-03-31 | $1.59M 10-Q · filed 2025-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |